About
Corticosteroids
Areas of Focus
Categories
Small Molecule PharmaceuticalSeattle/Pacific Northwest
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
135
By Phase
PHASE2: 3PHASE1: 2
By Status
COMPLETED: 3TERMINATED: 2
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05436639Lead Sponsor
SPI-62 as a Treatment for Hypercortisolism Related to a Benign Adrenal Tumor
PHASE2Terminated
30 participants
Started: Jul 1, 2023 · Completed: Feb 18, 2025
NCT05307328Lead Sponsor
SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome
PHASE2Completed
26 participants
Started: Sep 1, 2022 · Completed: Aug 1, 2025
NCT05436652Lead Sponsor
A Trial of Prednisolone in Combination With SPI-62 or Placebo in Subjects With Polymyalgia Rheumatica (PMR)
PHASE2Completed
66 participants
Started: Jul 22, 2022 · Completed: Apr 25, 2025
NCT06281236Lead Sponsor
A Trial of Prednisolone in Combination With SPI-62 in Participants With Polymyalgia Rheumatica (PMR)
PHASE1Terminated
1 participants
Started: Feb 22, 2022 · Completed: Apr 25, 2025
NCT05409027Lead Sponsor
A Study to Assess 11 Beta-hydroxysteroid Dehydrogenase Type 1 Inhibition in Adipose Tissue by SPI-62
PHASE1Completed
12 participants
Started: Jul 23, 2021 · Completed: Feb 7, 2024
Locations (1)
Headquarters
Portland, OR, United States
Map
Loading map...